ADVANCED CLINICAL CONSULTING LTD
Executive Summary
Advanced Clinical Consulting Ltd demonstrates a healthy financial position typical of a newly formed micro company, with positive liquidity and solvency indicators. While no symptoms of financial distress are present, ongoing monitoring and prudent management are essential to build resilience and enable growth. With focused attention on cash flow, reserves, and governance, the company is well-positioned for a stable financial future.
View Full Analysis Report →Company Analysis
This analysis is opinion only and should not be interpreted as financial advice.
ADVANCED CLINICAL CONSULTING LTD - Analysis Report
Financial Health Assessment Report for Advanced Clinical Consulting Ltd
1. Financial Health Score: B
Explanation:
Advanced Clinical Consulting Ltd shows a sound and stable financial footing for a micro-entity in its first full accounting period. The company's balance sheet reveals a positive net asset position and healthy working capital, indicating good liquidity and financial stability. However, as a newly incorporated company with limited financial history and a small asset base, there is room for growth and strengthening of reserves before reaching an 'A' grade.
2. Key Vital Signs
Metric | Value (£) | Interpretation (Medical Analogy) |
---|---|---|
Fixed Assets | 642 | "Long-term body structure" - modest investment in tangible assets, typical for a start-up. |
Current Assets | 10,516 | "Blood supply" - healthy cash and receivables to meet short-term needs. |
Current Liabilities | 4,284 | "Short-term obligations" - manageable debts due within a year. |
Net Current Assets | 6,232 | "Working capital" - positive buffer indicating liquidity strength. |
Total Assets less Current Liabilities | 6,874 | "Overall strength" - assets comfortably cover short-term debts. |
Net Assets / Shareholders’ Funds | 6,575 | "Equity health" - positive shareholder equity, indicating solvency. |
Additional Notes:
- The company has no overdue filings or penalties, which supports regulatory compliance—a key "immune system" function.
- Single director and sole shareholder control (75-100%) simplifies governance but concentrates risk.
- Operating in specialist medical and health activities with postgraduate education focus suggests niche expertise.
3. Diagnosis
Advanced Clinical Consulting Ltd is akin to a young patient showing good initial vitality but requiring ongoing care and monitoring. The financial "vital signs" show no immediate signs of distress: cash flow appears sufficient to meet current liabilities, and net assets indicate solvency. The company benefits from a strong equity base given its start-up status, with no audit requirements easing administrative burdens.
However, the micro size and limited asset base imply sensitivity to operational shocks or unexpected expenses. The reliance on a single director/shareholder means leadership continuity and decision-making agility are critical but also represent a concentration risk.
The absence of debt beyond short-term creditors is positive, suggesting the company is not over-leveraged. The modest fixed assets and positive working capital indicate a lean operation with healthy cash flow management.
4. Recommendations
To ensure continued financial wellness and growth, the following actions are advised:
Cash Flow Monitoring: Maintain a "healthy blood supply" by regularly reviewing cash inflows and outflows to avoid liquidity shortages. Consider projecting cash flow for at least 6-12 months ahead.
Build Reserves: Aim to accumulate retained earnings ("strengthening the immune system") to provide a buffer against future uncertainties or investment needs.
Diversify Control: If possible, consider expanding the management team or involving additional stakeholders to reduce concentration risk and enhance governance.
Asset Investment: As the business grows, evaluate opportunities to invest in fixed assets or intangible assets (like technology or intellectual property) to support scaling.
Compliance Vigilance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain a good regulatory standing.
Strategic Planning: Develop a business plan including revenue growth targets, cost management strategies, and potential funding needs to transition from a micro-entity to a stable small enterprise.
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company